Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+1.89%
SPX
+1.52%
IXIC
+1.88%
FTSE
+0.13%
N225
+0.05%
AXJO
-0.57%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Key Stats

Market Cap
818.30K
Dividend Yield
0.00%
P/E Ratio
-0.16
EPS
-7.06
Revenue
-
Avg. Volume
66.60K

About

What does SLRX do?
Salarius Pharmaceuticals, a clinical-stage biopharmaceutical company based in Houston, Texas, focuses on developing innovative cancer treatments, including seclidemstat and SP-3164. The company went public on January 29, 2015.
Sector
💻 Health Care
IPO
CEO
Employees
2
Headquarters
Texas, USA
Website
http://www.salariuspharma.com

Recently from Cashu

publisher logo
Cashu

Salarius Pharmaceuticals: Key Updates and Developments in Recent Progress

about 1 month ago
publisher logo
Cashu

Salarius Pharmaceuticals: Key Developments and Stock Insights

about 1 month ago
publisher logo
Cashu

Salarius Pharmaceuticals: Key Updates on Company Developments and Future Outlook

about 1 month ago
Stocks
Health Care
slrx
Salarius Pharmaceuticals
NASDAQ: SLRX
+0.37 (+6.95%)
5.69
USD
At close at Aug 22, 20:40 UTC
Summary
News
Signals
Benchmarks
Financials